Amwell expands clinical programs portfolio to include Hello Heart cardiovascular health risk management solution
October 08, 2024 07:05 ET
|
Amwell
Amwell today announced Hello Heart is a partner in the Amwell clinical programs portfolio available on the Amwell Converge™ platform.
Percutaneous Transluminal Angioplasty Markets Report, 2020-2024 & 2025-2030 Featuring Medtronic, Terumo, Cardinal Health, Boston Scientific, Teleflex, J&J, Abbott, Stryker, BD and Co, and Cook
September 30, 2024 06:58 ET
|
Research and Markets
Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Global Percutaneous Transluminal Angioplasty (PTA) Market (2024 Edition): Analysis By Product Type (Balloon Catheters, Stents, Guidewires, Others), By...
Cardiology IT Workflow Solutions Business Research Report 2024: Rising Global Burden of Cardiovascular Diseases, Despite Efforts Aimed at Prevention to Spur Growth - Forecast to 2030
September 20, 2024 07:15 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "Cardiology IT Workflow Solutions - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for...
US Cardiologists Industry Analysis Trends and Forecasts 2024-2029: Rising Obesity and Heart Disease Rates Among U.S. Population Heighten Need for Cardiologist Care
August 27, 2024 04:01 ET
|
Research and Markets
Dublin, Aug. 27, 2024 (GLOBE NEWSWIRE) -- The "Cardiologists in the US - Market Size, Industry Analysis, Trends and Forecasts (2024-2029)" report has been added to ResearchAndMarkets.com's...
19th Annual Cardiometabolic Health Congress: Honoring the Life and Legacy of CMHC Co-Chair Dr. George L. Bakris
August 14, 2024 12:00 ET
|
Cardiometabolic Health Congress
Boca Raton, FL, Aug. 14, 2024 (GLOBE NEWSWIRE) -- For nearly two decades, Dr. George L. Bakris was a pillar of the Cardiometabolic Health Congress (CMHC), generously sharing his expertise, passion,...
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech
August 05, 2024 10:16 ET
|
NodThera
NodThera Named a ‘Fierce 15’ Company by Fierce Biotech Philadelphia, PA, August 5, 2024 - NodThera, a leading clinical-stage biotech delivering a paradigm shift in the treatment of chronic...
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
August 02, 2024 16:30 ET
|
Tourmaline Bio, Inc.
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer
August 01, 2024 07:00 ET
|
NodThera
NodThera Announces Appointment of Greg Chow as Chief Financial and Business Officer Greg brings over 25 years of public and private company leadership experience Philadelphia, PA, August 1, 2024 -...
U.S. Cardiology Procedures Market Analysis Report 2024-2030: Interventional Procedures, Peripheral Vascular Procedures, Heart Rhythm Management Procedures Size, Share & Trends
July 11, 2024 10:41 ET
|
Research and Markets
Dublin, July 11, 2024 (GLOBE NEWSWIRE) -- The "U.S. Cardiology Procedures Market Size, Share & Trends Analysis Report by Procedures (Interventional Procedures, Peripheral Vascular Procedures,...
Boehringer Ingelheim’s survodutide shows breakthrough improvement in liver fibrosis with no worsening of MASH in 64.5% of patients with F2 and F3 fibrosis
June 07, 2024 04:30 ET
|
Boehringer Ingelheim
News builds on previously announced primary endpoint, which showed up to 83.0% of adults achieved statistically significant improvement in metabolic dysfunction-associated steatohepatitis (MASH)...